First Time Loading...

Globeimmune Inc
OTC:GBIM

Watchlist Manager
Globeimmune Inc Logo
Globeimmune Inc
OTC:GBIM
Watchlist
Price: 0.0002 USD Market Closed
Updated: Apr 27, 2024

Globeimmune Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Globeimmune Inc
Net Income (Common) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Globeimmune Inc
OTC:GBIM
Net Income (Common)
-$2.8m
CAGR 3-Years
42%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Income (Common)
$4.8B
CAGR 3-Years
2%
CAGR 5-Years
-3%
CAGR 10-Years
2%
Gilead Sciences Inc
NASDAQ:GILD
Net Income (Common)
$5.7B
CAGR 3-Years
258%
CAGR 5-Years
1%
CAGR 10-Years
6%
Amgen Inc
NASDAQ:AMGN
Net Income (Common)
$6.7B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income (Common)
$3.6B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income (Common)
$4B
CAGR 3-Years
4%
CAGR 5-Years
10%
CAGR 10-Years
25%

See Also

What is Globeimmune Inc's Net Income (Common)?
Net Income (Common)
-2.8m USD

Based on the financial report for Dec 31, 2015, Globeimmune Inc's Net Income (Common) amounts to -2.8m USD.

What is Globeimmune Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
36%

Over the last year, the Net Income (Common) growth was 88%. The average annual Net Income (Common) growth rates for Globeimmune Inc have been 42% over the past three years , 36% over the past five years .